spacer
spacer

PDBsum entry 5h8n

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transport protein PDB id
5h8n

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
276 a.a.
282 a.a.
Ligands
GLU
5YD
GLY
Metals
_CA
Waters ×138
PDB id:
5h8n
Name: Transport protein
Title: Structure of the human glun1/glun2a lbd in complex with nam
Structure: Glutamate receptor ionotropic, nmda 2a,glutamate receptor ionotropic, nmda 2a. Chain: a. Fragment: unp residues 401-539, gt linker, unp residues 661-802. Synonym: glun2a, glutamate [nmda] receptor subunit epsilon-1, n- methyl d-aspartate receptor subtype 2a, hnr2a. Engineered: yes. Glutamate receptor ionotropic, nmda 1,glutamate receptor ionotropic, nmda 1.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: grin2a, nmdar2a. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: grin1, nmdar1. Expression_system_taxid: 562
Resolution:
2.50Å     R-factor:   0.182     R-free:   0.236
Authors: H.J.A.Wallweber,P.J.Lupardus
Key ref: D.H.Hackos et al. (2016). Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Neuron, 89, 983-999. PubMed id: 26875626 DOI: 10.1016/j.neuron.2016.01.016
Date:
23-Dec-15     Release date:   24-Feb-16    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q12879  (NMDE1_HUMAN) -  Glutamate receptor ionotropic, NMDA 2A from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1464 a.a.
276 a.a.
Protein chain
Pfam   ArchSchema ?
Q05586  (NMDZ1_HUMAN) -  Glutamate receptor ionotropic, NMDA 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
938 a.a.
282 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 

 
DOI no: 10.1016/j.neuron.2016.01.016 Neuron 89:983-999 (2016)
PubMed id: 26875626  
 
 
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
D.H.Hackos, P.J.Lupardus, T.Grand, Y.Chen, T.M.Wang, P.Reynen, A.Gustafson, H.J.Wallweber, M.Volgraf, B.D.Sellers, J.B.Schwarz, P.Paoletti, M.Sheng, Q.Zhou, J.E.Hanson.
 
  ABSTRACT  
 
To enhance physiological function of NMDA receptors (NMDARs), we identified positive allosteric modulators (PAMs) of NMDARs with selectivity for GluN2A subunit-containing receptors. X-ray crystallography revealed a binding site at the GluN1-GluN2A dimer interface of the extracellular ligand-binding domains (LBDs). Despite the similarity between the LBDs of NMDARs and AMPA receptors (AMPARs), GluN2A PAMs with good selectivity against AMPARs were identified. Potentiation was observed with recombinant triheteromeric GluN1/GluN2A/GluN2B NMDARs and with synaptically activated NMDARs in brain slices from wild-type (WT), but not GluN2A knockout (KO), mice. Individual GluN2A PAMs exhibited variable degrees of glutamate (Glu) dependence, impact on NMDAR Glu EC50, and slowing of channel deactivation. These distinct PAMs also exhibited differential impacts during synaptic plasticity induction. The identification of a new NMDAR modulatory site and characterization of GluN2A-selective PAMs provide powerful molecular tools to dissect NMDAR function and demonstrate the feasibility of a therapeutically desirable type of NMDAR enhancement.
 

 

spacer

spacer